Blog - Page 84 of 5734 - QualityStocks

WednesdayJun 03, 2026 12:48 pm

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Expands Sapu003 Phase 1b Program, Appoints Global CRO for International Study Execution

Oncotelic Therapeutics (OTCQB: OTLC) and Sapu Nano announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection) and the appointment of Global Clinical Trials (GCT) as the lead contract research organization for international execution of Study SP-03-B101. The move follows recent regulatory approvals supporting study expansion and marks the transition of the Sapu003 program from an Australia-based clinical effort toward a broader multinational development strategy, including planned expansion into Europe. SP-03-B101 is an open-label Phase 1b dose-escalation study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary anti-tumor activity of Sapu003 in patients with advanced mTOR-sensitive solid tumors. The company said GCT…

WednesdayJun 03, 2026 12:38 pm

QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Advances Kilogram-Scale Manufacturing for ONC010 Program

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) announced the successful advancement of kilogram-scale manufacturing activities for the B4 precursor component used in the development of ONC010, the company's lead nanoparticle-formulated Polynucleotide Kinase Phosphatase (PNKP) inhibitor technology. Conducted through its chemistry, manufacturing and controls collaboration with Dalton Pharma Services, the effort resulted in the production and isolation of approximately 952 grams of B4 material, supporting future formulation development, GMP production and planned clinical studies. The company said the manufacturing milestone strengthens its integrated development strategy and supports the establishment of a scalable production…

WednesdayJun 03, 2026 12:23 pm

QualityStocksNewsBreaks – VolitionRx Ltd. (NYSE American: VNRX) Expands Patent Portfolio with Ebola Triage Application

VolitionRx Limited (NYSE American: VNRX) announced the filing of a strategic patent application covering the use of its proprietary Nu.Q technology for triaging and monitoring patients suspected of having contracted the Ebola virus. The application builds on the company's existing Nu.Q(R) NETs test, which measures circulating nucleosomes and neutrophil extracellular traps as early indicators of hyper-inflammation associated with septic shock and mortality. Volition said its CE-Marked automated Nu.Q NETs assay and recently developed finger-prick lateral flow detection prototype could provide a low-cost bedside triage solution during Ebola outbreaks, particularly in resource-constrained regions. The company is seeking partnerships with global health organizations, pharmaceutical developers, NGOs and distribution partners to support field…

WednesdayJun 03, 2026 11:50 am

QualityStocksNewsBreaks – Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) Renews Marketing Agreement With Euro Digital Media

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising. Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) announced the renewal of its marketing agreement with Euro Digital Media Ltd. for an additional 60 to 90 days, or until the allocated budget is exhausted. The agreement follows previous announcements made on Oct. 15, 2025, Jan. 16, 2026, and March 10, 2026, and may be extended or shortened at the discretion of management. Under the agreement, Euro Digital will provide digital marketing services including campaign creation and management, keyword research, remarketing initiatives, advertising optimization, landing page development and other online marketing activities designed to increase awareness of…

WednesdayJun 03, 2026 10:30 am

Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) Strengthens Position in Rapidly Growing Rare Earth Sector

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising. The importance of rare earth elements has grown significantly alongside the global energy transition. Canamera Energy Metals is accelerating exploration activities at its Turvolândia rare earth project in Minas Gerais, Brazil. The company also filed an independent NI 43-101 technical report for its Jaguaribe rare earth project in Ceará State, Brazil. Rare earth elements are becoming increasingly essential to the modern global economy, powering technologies that range from electric vehicles and renewable energy systems to advanced defense applications and consumer electronics. As governments…

WednesdayJun 03, 2026 10:00 am

QualityStocksNewsBreaks – Rail Vision Ltd. (NASDAQ: RVSN, FSE: C80) ShuntingYard System Integrated Into Railserve Yard Safety Platform

Rail Vision (NASDAQ: RVSN, FSE: C80) announced that its AI-powered ShuntingYard system has been integrated into Railserve’s newly introduced YardGUARD industrial railyard safety system, serving as a core technology within the WatchGUARD situational awareness and obstacle detection solution. The integration follows the companies’ recently announced memorandum of understanding and combines Rail Vision’s perception technology with communications and cloud-based monitoring capabilities to provide real-time visibility, obstacle detection, synchronized alerts and automatic braking support. The ShuntingYard system is being showcased this week at Railway Interchange 2026 in Omaha, Nebraska, as part of Railserve’s broader yard safety platform. To view the full press…

WednesdayJun 03, 2026 9:50 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Advanced Drug Delivery and Platform-Based Biotech Innovation

Oncotelic Therapeutics (OTCQB: OTLC) was featured in a BioMedWire editorial exploring how biotechnology companies are increasingly leveraging advanced drug-delivery technologies, nanotechnology platforms and artificial intelligence to enhance existing therapies and expand treatment opportunities. The article highlights Oncotelic’s Sapu003 program, Deciparticle(TM) platform and PDAOAI initiative as part of a broader industry trend toward scalable, multi-application biotechnology platforms capable of supporting oncology and rare disease programs. The editorial also discusses developments from CytoDyn Inc. (OTCQB: CYDY), which is advancing leronlimab for oncology indications; Revolution Medicines Inc. (NASDAQ: RVMD), which reported positive Phase 3 results for daraxonrasib in pancreatic cancer; Moderna Inc. (NASDAQ:…

WednesdayJun 03, 2026 9:45 am

Earth Science Tech Inc. (ETST) Pairs Healthcare Expansion with Aggressive Share Repurchases

Earth Science Tech has evolved into a diversified healthcare holding company with operations spanning telemedicine, compounding pharmacies, clinical support services and healthcare fulfillment. In addition, the company has actively reduced its share count through a series of share repurchases documented in SEC filings and share structure records. Earth Science Tech repurchased 3.7 million shares over the nine months ended December 31, 2025, spending approximately $647,000. Management continues to emphasize shareholder value through balance-sheet management alongside acquisitions and operating growth. The company is scheduled to present to investors at the Planet MicroCap Las Vegas 2026 conference in June. For many investors…

WednesdayJun 03, 2026 9:40 am

QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Featured in AINewsWire Editorial on AI Energy Demand and Natural Hydrogen Opportunity

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) was featured in an AINewsWire editorial examining how surging electricity demand from artificial intelligence infrastructure is accelerating interest in natural hydrogen as a potential large-scale energy solution. The article highlights MAX Power’s Lawson Project in Saskatchewan, where the company has confirmed North America’s first subsurface natural hydrogen system, and discusses its efforts to advance commercial evaluation of natural hydrogen as a potential source of scalable, off-grid baseload power for future AI and industrial applications. The…

WednesdayJun 03, 2026 9:30 am

QualityStocksNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML)

Canada News Group News Commentary Issued on behalf of Greenland Mines Ltd Greenland Mines (NASDAQ: GRML) is expanding its position in the critical minerals sector through the advancement of its Skaergaard palladium-gold-platinum project in Greenland and its planned acquisition of the Sarfartoq neodymium-praseodymium ("NdPr") rare-earths project. According to company disclosures, Skaergaard hosts a substantial palladium-equivalent resource and recently demonstrated significant metal-price leverage in an independent sensitivity study by SLR Consulting, while the Sarfartoq transaction would add an advanced rare-earths asset to the company's portfolio and establish Neo Performance Materials as a strategic shareholder and future offtake partner. Greenland Mines joins…

Site Search

Company Search